Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)
Clinical trial NCT01244035 · COMPLETED
Trial details
- NCT number
- NCT01244035
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-19
- Primary completion
- 2010-12-23
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.